• Author: P. Michael Ho
Clear all

First-line β-blocker use for hypertension in the Veterans Health Administration

Abstract: Importance: Starting in 2014, US guidelines have not recommended β-blockers for first-line treatment of hypertension in the absence of compelling indications due to …

Trends in initial antihypertensive medication prescribing among >2.8 million Veterans newly diagnosed with hypertension, 2000 to 2019

Abstract: Background: Among patients diagnosed with high blood pressure (BP), initial dual therapy has been recommended for patients with high pretreatment systolic BP …

Older Veterans’ perspectives on participation in a clinical exercise program: A qualitative study of the VA Gerofit exercise program

Abstract: Objectives: We explored the perspectives of older veterans in Gerofit, a Department of Veteran Affairs (VA) supervised clinical exercise program, to understand the …

Trends and site-level variation of novel cardiovascular medication utilization among patients admitted for heart failure or coronary artery disease in the US Veterans Affairs system: 2017-2021

Abstract: OBJECTIVE: We assessed trends in novel cardiovascular medication utilization in US Veterans Affairs (VA) for angiotensin receptor-neprilysin inhibitors (ARNI), …

Improving Transitions of Care for Veterans Transferred to Tertiary VA Medical Centers

Abstract: Veterans are often transferred from “spoke” Veterans Administration (VA) clinics or hospitals to “hub” tertiary VA hospitals for advanced inpatient care, but they …